1. FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page news
    Dismiss Notice

Qui tam relator question

Discussion in 'Ask a Whistleblower Attorney' started by anonymous, Jan 14, 2021 at 2:21 PM.

Tags: Add Tags
  1. #1 anonymous, Jan 14, 2021 at 2:21 PM
    anonymous

    anonymous Guest

    I have heard that when a whistleblower lawsuit is filed only the 1st person to file is rewarded (the 2nd and 3rd just have their names outed but receive no benefit).

    Is this true?
     
    Quote

  2. #2 anonymous, Aug 5, 2021 at 12:40 PM
    anonymous

    anonymous Guest

    Yep
     
    Quote
Reply to Thread